CSIMarket
 

Healthcare Sector

Biotechnology & Drugs Industry  


Data by Company within Biotechnology & Drugs Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Abbvie Inc $ 143,622 $ 34,300 $ 7,573 26,000
Arca Biopharma Inc $ 11 - $ -5 -
American Bio Medica Corp $ 32 $ 4 $ -1 -
Acorda Therapeutics inc $ 34 $ 176 $ -232 -
Aclaris Therapeutics Inc $ 75 $ 1 $ -139 -
Actavis Plc $ 3,990 $ 10,573 $ -751 19,200
Ocata Therapeutics, Inc. - - $ 0 -
Adaptimmune Therapeutics Plc $ 6,887 $ 2 $ -138 -
Fennec Pharmaceuticals Inc. - - $ 0 -
Adma Biologics Inc $ 212 $ 36 $ -54 -
Adverum Biotechnologies Inc $ 1,559 $ 2 $ -73 -
Aerie Pharmaceuticals Inc $ 594 $ 79 $ -201 -
Agenus Inc $ 569 $ 85 $ -174 -
Allergan plc $ 64,063 $ 16,096 $ -2,479 10,500
Applied Genetic Technologies Corp $ 136 $ 42 $ -42 -
Akers Biosciences Inc $ 8 $ 1 $ -7 -
Alder Biopharmaceuticals Inc $ 1,579 - $ -317 -
Alliance Bioenergy Plus, Inc. $ 13 - $ -11 -
Amarillo Biosciences Inc $ 9 $ 0 $ -2 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amgen Inc $ 147,930 $ 32,341 $ 7,675 17,900
Albany Molecular Research Inc $ 928 $ 681 $ -60 -
Amyris Inc $ 676 $ 167 $ -293 440
Alpha Network Alliance Ventures Inc. $ 7 $ 0 $ -1 7
Aeolus Pharmaceuticals, Inc. $ 0 $ 1 $ -4 -
Armata Pharmaceuticals Inc $ 3 $ 0 $ -23 -
Aptevo Therapeutics Inc $ 28 $ 32 $ -26 -
Ariad Pharmaceuticals Inc - - $ 0 -
Arno Therapeutics, Inc - - $ 0 -
Assembly Biosciences inc $ 829 $ 16 $ -97 -
Asterias Biotherapeutics, Inc. $ 51 $ 3 $ -24 -
Atara Biotherapeutics Inc $ 937 - $ -312 -
Kubota Pharmaceutical Holdings Co Ltd - - $ 0 -
Anavex Life Sciences Corp $ 279 $ 0 $ -25 -
Axim Biotechnologies Inc $ 22 $ 1 $ -6 -
Axovant Gene Therapies Ltd $ 38 - $ -73 -
Aytu Bioscience Inc $ 47 $ 14 $ -25 -
Azurrx Biopharma Inc $ 22 - $ -16 -
Acasti Pharma Inc $ 185 - $ 0 -
Brainstorm Cell Therapeutics Inc $ 374 - $ -26 -
Biocryst Pharmaceuticals Inc $ 852 $ 48 $ -115 -
Beesfree, Inc. - - $ 0 -
Bg Medicine, Inc. - - $ 0 -
U.s. Stem Cell, Inc. - $ 4 $ -4 -
Premier Biomedical Inc $ 0 $ 0 $ 0 -
Biogen Inc $ 48,274 $ 14,422 $ 5,872 7,550
Immucor Inc - - $ 0 -
Bluebird Bio Inc $ 3,678 $ 54 $ -828 -
Mj Biotech, Inc. - - $ -1 2
Bionovo Inc - - $ 0 -
Audentes Therapeutics Inc $ 2,664 - $ -166 -
Bohai Pharmaceuticals Group, Inc. $ 7 $ 165 $ 22 -
Timber Pharmaceuticals Inc $ 1 $ 0 $ -8 -
Organicell Regenerative Medicine Inc $ 5 $ 1 $ -5 -
Biorestorative Therapies, Inc. $ 0 $ 0 $ -17 -
Boston Therapeutics Inc $ 1 $ 0 $ -4 -
Lineage Cell Therapeutics Inc $ 138 $ 3 $ -60 -
Burzynski Research Institute Inc $ 3 - $ -2 -
Cadence Pharmaceuticals Inc - - $ 0 -
Cannis Inc $ 619 $ 3 $ -14 -
Capricor Therapeutics Inc $ 31 $ 1 $ -7 -
Capstone Therapeutics Corp. $ 816 - $ -4 -
Casi Pharmaceuticals Inc $ 230 $ 7 $ -55 -
Catalyst Biosciences Inc $ 86 $ 1 $ -44 -
Cellular Biomedicine Group Inc $ 294 $ 0 $ -52 -
Axcella Health Inc $ 119 - $ -62 -
China Botanic Pharmaceutical - - $ 0 -
China Biologic Products Holdings Inc - $ 504 $ 163 -
Cellcyte Genetics Corp. - - $ 0 -
Cidara Therapeutics Inc $ 142 - $ -39 -
Chromadex Corp $ 299 $ 51 $ -30 -
Cardax Inc $ 2 $ 1 $ -5 -
Cen Biotech Inc - - $ -6 -
Cerecor Inc $ 163 $ 4 $ -14 -
Compugen Ltd $ 1,035 $ 18 $ -27 -
Gossamer Bio Inc $ 810 - $ -202 -
Coherus Biosciences inc $ 1,329 $ 435 $ 145 -
Chelsea Therapeutics International, Ltd. - - $ 0 -
China Kangtai Cactus Bio-tech, Inc. - - $ 0 -
Celldex Therapeutics Inc $ 216 $ 5 $ -46 -
Igm Biosciences Inc $ 2,185 - $ 0 -
Cell Medx Corp $ 32 $ 0 $ -1 4
United Cannabis Corp $ 1 $ 16 $ -21 -
Cannabics Pharmaceuticals Inc - $ 0 $ 2 -
Compass Biotechnologies Inc. - - $ 0 -
Cohbar Inc - - $ -14 -
Cocrystal Pharma Inc $ 76 $ 2 $ -53 -
Core Lithium Corp. $ 18 - $ -4 -
Cannapharmarx Inc $ 40 - $ -24 -
Curis Inc $ 43 $ 11 $ -32 -
Crispr Therapeutics Ag $ 5,721 $ 289 $ 46 -
American Cryostem Corp $ 10 $ 0 $ -1 -
Champions Oncology Inc $ 128 $ 31 $ 0 -
Oyster Point Pharma Inc $ 571 - $ 0 -
Cyclo Therapeutics Inc $ 18 $ 1 $ -8 6
Cytomx Therapeutics Inc $ 391 $ 78 $ -76 -
Citius Pharmaceuticals Inc $ 44 - $ -17 1
Cel Sci Corp $ 526 - $ -31 -
Cv Sciences, Inc. - $ 22 $ -5 -
Cyanotech Corp $ 14 $ 32 $ 0 124
Cytodyn Inc $ 2,253 - $ -82 -
Cytrx Corp $ 23 - $ -7 -
Enochian Biosciences Inc $ 280 - $ -24 -
Diadexus, Inc. - - $ 0 -
Diffusion Pharmaceuticals Inc $ 30 - $ -12 -
Delmar Pharmaceuticals Inc $ 9 - $ 10 -
Dimension Therapeutics, Inc. $ 149 $ 17 $ -56 -
Dna Testing Centers Corp - $ 0 $ 0 -
Dendreon Corp - - $ 0 -
Aslan Pharmaceuticals Ltd $ 313 $ 3 $ -47 -
Noho, Inc. - - $ 0 -
Ds Healthcare Group, Inc. $ 0 $ 12 $ -6 105
Outlook Therapeutics Inc - $ 8 $ -50 -
Emergent Biosolutions Inc $ 4,913 $ 1,108 $ 68 -
Pds Biotechnology Corp $ 5 - $ -18 -
Eiger Biopharmaceuticals Inc $ 228 - $ -68 -
Empowered Products, Inc. - - $ 0 -
Endonovo Therapeutics Inc $ 1 $ 0 $ -11 -
Madrigal Pharmaceuticals inc $ 1,664 - $ -105 -
Entremed Inc - - $ 0 -
Entest Group Inc $ 2 - $ 0 -
Enumeral Biomedical Holdings, Inc. $ 0 $ 2 $ -13 -
Enzon Pharmaceuticals Inc $ 8 $ 0 $ -1 -
Enzymotec Ltd. - - $ 0 124
Entia Biosciences, Inc. $ 0 $ 0 $ -1 -
Eastgate Biotech Corp - $ 0 $ -3 -
Fate Therapeutics Inc $ 2,758 $ 11 $ -112 -
Fulgent Genetics Inc $ 422 $ 35 $ 0 -
Foamix Pharmaceuticals Ltd $ 193 $ 3 $ 95 68
Global Future City Holding Inc. $ 3 $ 3 $ -5 -
Sellas Life Sciences Group Inc $ 2 $ 1 $ -27 -
89bio Inc $ 456 - $ 0 -
Gentium S.p.a. - - $ 0 -
Synageva Biopharma Corp - - $ 0 -
Gilead Sciences Inc $ 96,926 $ 22,716 $ 4,934 7,000
Glucose Health, Inc. $ 4 - $ 0 1
Genocea Biosciences Inc $ 56 - $ -36 -
Aevi Genomic Medicine, Inc. $ 11 - $ -18 -
Green Planet Bio Engineering Co Ltd $ 1 - $ 0 -
Optec International, Inc. $ 59 $ 0 $ -1 -
Guided Therapeutics Inc $ 34 $ 0 $ 1 -
Genethera Inc $ 2 - $ 0 -
Gtx Corp $ 2 $ 1 $ 0 -
Halozyme Therapeutics Inc $ 3,841 $ 164 $ -80 -
Hubei Minkang Pharmaceutical Ltd. - - $ 0 -
Health Discovery Corp $ 3 $ 2 $ 1 -
Aim Immunotech Inc $ 31 $ 0 $ -10 -
Inhibitor Therapeutics Inc $ 32 - $ -2 -
Hyperion Therapeutics Inc - - $ 0 -
Heska Corp $ 683 $ 124 $ -8 -
Hst Global Inc $ 0 - $ 0 -
Idera Pharmaceuticals Inc $ 58 $ 1 $ -37 -
Intelgenx Technologies Corp $ 21 $ 1 $ -11 -
Intellect Neurosciences, Inc. $ 0 - $ -15 -
Conversion Labs Inc $ 12 $ 14 $ -5 11
Epicure Charcoal, Inc. $ 0 - $ 0 -
Immunomedics Inc $ 9,020 $ 2 $ -363 -
Immune Therapeutics Inc $ 0 - $ -9 -
Integrated Biopharma Inc $ 14 $ 53 $ 3 -
Infinity Pharmaceuticals Inc $ 62 $ 3 $ -47 23
Artemis Therapeutics Inc - - $ 0 1
Innovus Pharmaceuticals, Inc. $ 2 $ 23 $ -8 -
Renovacare Inc - - $ -4 -
Jounce Therapeutics Inc $ 217 $ 148 $ 114 -
Juno Therapeutics, Inc. $ 9,815 $ 112 $ -437 -
Cadus Corp $ 42 - $ -3 -
Kite Pharma, Inc. $ 10,187 $ 32 $ -359 -
Lescarden Inc - - $ 0 -
Atyr Pharma Inc $ 29 $ 8 $ -16 -
Lixte Biotechnology Holdings Inc $ 59 - $ -2 -
La Jolla Pharmaceutical Company $ 118 $ 26 $ -93 -
Opiant Pharmaceuticals Inc - $ 39 $ 12 -
Lazuriton Nano Biotechnology (u.s.a.) Inc. - - $ 0 -
Apollo Endosurgery, Inc. - $ 64 $ -28 -
Brickell Biotech Inc $ 17 - $ -3 -
Mateon Therapeutics Inc $ 8 - $ 0 -
Mabvax Therapeutics Holdings, Inc. $ 2 - $ -20 -
Multicell Technologies, Inc. $ 0 $ 0 $ -1 -
Mctc Holdings Inc $ 3 - $ -2 -
Manhattan Pharmaceuticals Inc - - $ 0 -
Micromet, Inc. - - $ 0 -
Mj Pharmaceuticals Inc. - - $ 0 -
Cure Pharmaceutical Holding Corp - $ 1 $ 12 1
Momenta Pharmaceuticals inc $ 3,939 $ 29 $ -285 -
Mount Tam Biotechnologies, Inc. $ 1 - $ -1 -
Satsuma Pharmaceuticals Inc $ 443 - $ 0 -
Myriad Genetics Inc $ 852 $ 682 $ -22 -
Mymetics Corp $ 14 $ 1 $ -5 -
Myokardia Inc $ 4,337 $ 22 $ -309 -
Myrexis, Inc. - - $ 0 -
Navidea Biopharmaceuticals Inc $ 81 $ 1 $ -11 -
Nascent Biotech Inc $ 4 - $ -4 -
Neurocrine Biosciences Inc $ 12,761 $ 887 $ 177 -
Caladrius Biosciences Inc - $ 36 $ -19 -
Northsight Capital, Inc. - $ 0 $ -2 -
Neogen Corp $ 4,105 $ 419 $ 59 -
Nexus Biopharma Inc - - $ 0 -
Nantkwest Inc $ 1,387 $ 0 $ -66 -
Neoleukin Therapeutics Inc $ 636 - $ -76 -
Biovie Inc - - $ 2 -
Nutra Pharma Corp. $ 2 $ 0 $ -7 -
Nanostring Technologies Inc $ 1,335 $ 124 $ -57 -
Intellia Therapeutics Inc $ 1,241 $ 46 $ -109 -
Nbty Inc - - $ 0 -
Nugene International, Inc. - - $ 0 8
Nutrastar International Inc. - - $ 0 -
Novavax Inc $ 4,278 $ 18 $ -115 -
N-viro International Corporation - - $ 0 -
Obalon Therapeutics Inc $ 5 $ 2 $ -21 -
Oncbiomune Pharmaceuticals Inc $ 0 $ 0 $ -10 -
Oncocyte Corp $ 79 - $ -26 -
Spark Therapeutics Inc $ 4,257 $ 58 $ -80 -
Organovo Holdings Inc $ 81 $ 3 $ -19 -
Ayala Pharmaceuticals Inc $ 47 - $ 0 -
Orgenesis Inc $ 101 $ 28 $ -57 -
Osiris Therapeutics, Inc. $ 656 $ 113 $ 5 -
Oncovista Innovative Therapies, Inc - - $ 0 -
Oxford Immunotec Global Plc $ 357 $ 73 $ -6 -
Mateon Therapeutics Inc - - $ -11 -
Gt Biopharma Inc $ 4 - $ -36 -
Prolor Biotech, Inc. - - $ 0 -
Procyon Corp $ 2 $ 5 $ 0 -
Pdl Biopharma Inc $ 348 $ 22 $ -109 -
Quint Media Inc. - - $ 0 -
Petvivo Holdings Inc $ 16 $ 0 $ -2 4
Protokinetix Inc $ 28 - $ -8 -
Pulse Biosciences Inc $ 215 $ 1 $ -49 -
Protalix Biotherapeutics Inc $ 62 $ 34 $ -9 -
Pharmacyte Biotech Inc $ 32 - $ -4 -
Pluristem Therapeutics Inc $ 158 $ 1 $ -29 -
Frequency Therapeutics Inc $ 709 - $ 0 -
Proteo Inc $ 1 $ 0 $ 0 -
Protagonist Therapeutics Inc $ 485 $ 2 $ -83 -
Proteostasis Therapeutics Inc $ 70 $ 6 $ -55 -
Pulmatrix Inc $ 34 $ 11 $ -20 -
Pivot Pharmaceuticals Inc. $ 13 - $ -7 -
Q Biomed Inc $ 32 $ 0 $ -14 8
Quidel Corp $ 20,934 $ 562 $ 88 -
Qiagen N v $ 10,103 $ 1,526 $ -41 -
Quest Patent Research Corp $ 3 $ 5 $ -1 2
Quotient Ltd $ 564 $ 32 $ -105 -
Quint Media Inc. - - $ 0 -
Rich Pharmaceuticals, Inc. $ 0 - $ 0 -
Regenocell Therapeutics, Inc. - - $ 0 -
Receptos, Inc. - - $ 0 -
Ridgefield Acquisition Corp $ 3 - $ 0 -
Restorgenex Corp - - $ 0 -
Regen Biopharma Inc $ 0 - $ -5 -
Regado Biosciences Inc - - $ 0 -
Repligen Corp $ 6,834 $ 286 $ 23 -
Regenxbio Inc $ 1,423 $ 61 $ -118 -
Regenerx Biopharmaceuticals Inc $ 40 $ 0 $ -1 -
Relmada Therapeutics Inc $ 624 - $ -22 -
Repros Therapeutics Inc. $ 1,818 $ 0 $ -14 -
Respirerx Pharmaceuticals Inc $ 0 - $ -3 -
Aytu Bioscience, Inc. - - $ 0 -
Ruthigen, Inc. - - $ 0 -
Immunovant Inc $ 2,818 - $ -66 -
Radient Pharmaceuticals Corp - - $ 0 -
Strongbridge Biopharma Plc $ 199 $ 24 $ -44 -
Dyadic International Inc $ 246 $ 2 $ -4 -
Sangui Biotech International Inc $ 3 $ 0 $ 0 -
Seattle Genetics Inc $ 31,225 $ 956 $ -314 -
Sangamo Therapeutics Inc $ 1,264 $ 107 $ -96 -
Shengtai Pharmaceutical, Inc. - - $ 0 -
Skinovation Pharmaceutical Inc - - $ 0 -
Skinvisible Inc $ 0 $ 0 $ -2 -
Sun Biopharma Inc $ 42 - $ -6 -
Syndax Pharmaceuticals Inc $ 529 $ 2 $ -61 -
Soligenix Inc $ 47 $ 4 $ -15 -
Senesco Technologies Inc - - $ 0 -
Senesco Technologies Inc - - $ -8 -
Spero Therapeutics Inc $ 266 $ 12 $ -79 -
Spotlight Innovation Inc. $ 1 $ 0 $ -5 2
Sunwin Stevia International Inc $ 20 $ 29 $ -4 -
Intellicell Biosciences, Inc. - - $ 0 -
Savient Pharmaceuticals Inc - - $ 0 -
Tobira Therapeutics, Inc. - - $ 0 -
Tracon Pharmaceuticals Inc $ 10 $ 11 $ -19 -
Bio techne Corp $ 10,938 $ 755 $ 187 -
Telik Inc - - $ 0 -
Mabvax Therapeutics Holdings, Inc. - - $ 0 -
Tongli Pharmaceuticals (usa), Inc. $ 0 - $ 0 -
Tg Therapeutics inc $ 2,547 $ 0 $ -189 -
Tg Therapeutics, Inc. - - $ 0 -
Twinlab Consolidated Holdings Inc $ 71 $ 70 $ -38 -
Mitesco Inc $ 3 - $ -4 1
Targeted Medical Pharma, Inc. - - $ 0 -
Targacept Inc - - $ 0 -
Trovagene Inc $ 12 $ 0 $ -17 -
Therapeutic Solutions International Inc $ 13 $ 0 $ -1 -
Trius Therapeutics Inc - - $ 0 -
Taxus Pharmaceuticals Holdings, Inc. - - $ 0 -
Uluru Inc. $ 139 $ 1 $ -2 -
United Bancshares Inc - - $ 0 -
Vitality Biopharma Inc $ 3 $ 0 $ -4 -
Vericel Corporation $ 698 $ 123 $ -12 -
Meridian Bioscience Inc $ 1,072 $ 204 $ 21 -
Volitionrx Ltd $ 134 - $ -17 -
Viropharma Inc - - $ 0 -
Vermillion Inc $ 389 $ 5 $ -15 -
Vistagen Therapeutics Inc $ 23 - $ -22 -
Ventrus Biosciences Inc - - $ 0 -
Voyager Therapeutics Inc $ 493 $ 117 $ -41 -
Warner Chilcott Plc - - $ 0 -
Rapt Therapeutics Inc $ 616 - $ 0 -
Windtree Therapeutics Inc $ 96 $ 1 $ -27 -
Weikang Bio-technology Group Co., Inc. - - $ 0 -
Wave Life Sciences Ltd $ 345 $ 17 $ -197 -
Xenetic Biosciences Inc $ 6 - $ -13 -
Acceleron Pharma inc $ 5,372 $ 76 $ -138 -
Eidos Therapeutics Inc $ 1,856 - $ -49 -
Xstelos Holdings, Inc. - - $ 0 -
Vilacto Bio Inc. - $ 0 $ -1 1
Cabaletta Bio Inc $ 260 - $ 0 -
Iovance Biotherapeutics Inc $ 4 - $ -198 -
G1 Therapeutics Inc $ 804 - $ -130 -
Aerpio Pharmaceuticals Inc $ 54 - $ -19 -
Sienna Biopharmaceuticals, Inc. $ 4 - $ -48 -
Vir Biotechnology Inc $ 5,116 - $ 0 -
Qrons Inc $ 6 - $ -2 -
Krystal Biotech Inc $ 737 - $ -20 -
Springworks Therapeutics Inc $ 1,647 - $ 0 -
Galera Therapeutics Inc $ 182 - $ 0 -
Allena Pharmaceuticals Inc $ 36 - $ -44 -
Urogen Pharma Ltd $ 500 $ 8 $ -121 -
Eloxx Pharmaceuticals Inc $ 109 - $ -53 -
Cv Sciences Inc $ 56 $ 47 $ -12 -
Eyenovia Inc $ 49 - $ -21 -
Nightstar Therapeutics Plc $ 840 - $ -53 -
Phathom Pharmaceuticals Inc $ 975 - $ 0 -
Zai Lab Limited - $ 13 $ -195 -
Zymeworks Inc $ 1,708 $ 26 $ -163 -
Scpharmaceuticals Inc $ 153 - $ -31 -
Cannapowder Inc $ 12 - $ -3 -
Arcus Biosciences Inc $ 1,128 $ 15 $ -95 -
Clementia Pharmaceuticals Inc. $ 836 - $ 0 -
Oncternal Therapeutics Inc $ 38 $ 3 $ -33 -
Salarius Pharmaceuticals inc $ 14 $ 4 $ -7 -
Solid Biosciences Inc $ 142 - $ -114 -
Denali Therapeutics Inc $ 2,747 $ 26 $ 39 -
Cue Biopharma Inc $ 602 $ 2 $ -38 -
Homology Medicines Inc $ 701 $ 2 $ -115 -
Unum Therapeutics Inc $ 91 $ 14 $ -40 -
Nymox Pharmaceutical Corporation $ 228 $ 0 $ -13 -
Armo Biosciences, Inc. - - $ 0 -
Surface Oncology Inc $ 175 $ 40 $ -28 -
Evelo Biosciences Inc $ 142 - $ -88 -
Unity Biotechnology Inc $ 375 - $ -91 -
Avricore Health Inc. - - $ 0 -
Kazia Therapeutics Ltd $ 2 $ 1 $ -10 -
Bionovate Technologies Corp $ 62 - $ 0 -
Luckwel Pharmaceuticals Inc. - - $ 0 -
Aptose Biosciences Inc $ 481 - $ -32 -
Cellect Biotechnology Ltd $ 680 - $ 5 -
Gritstone Oncology Inc $ 261 $ 4 $ -103 -
Neuronetics Inc $ 34 $ 57 $ -34 -
Iterum Therapeutics Plc $ 18 - $ -99 -
Fennec Pharmaceuticals Inc - - $ -14 -
Kitov Pharma Ltd $ 17 $ 1 $ 6 -
Immuron Ltd - $ 2 $ -5 -
Genetic Technologies Ltd - $ 0 $ -6 -
Bionano Genomics Inc $ 17 $ 9 $ -32 -
Urovant Sciences Ltd $ 291 - $ -147 -
Nexien Biopharma Inc $ 5 - $ -6 -
Biofrontera Ag $ 319 $ 24 $ -10 -
Therapix Biosciences Ltd. - - $ 0 -
Cellectis S a $ 737 $ 15 $ -115 -
Replicel Life Sciences Inc. $ 4 - $ -2 -
Apollo Endosurgery inc $ 32 $ 48 $ -35 -
Medicure Inc - $ 15 $ -15 -
Erytech Pharma S a $ 144 - $ -70 -
Prana Biotechnology Ltd $ 11 $ 0 $ -8 -
Dbv Technologies S a - - $ -172 -
Midatech Pharma Plc - $ 2 $ -15 -
Biondvax Pharmaceuticals Ltd $ 12,736 - $ -109 -
Vaxart Inc $ 497 $ 7 $ -19 -
Predictive Oncology Inc $ 7 $ 1 $ -21 -
Livongo Health Inc $ 10,277 $ 69 $ -6 -
Merus N v $ 447 - $ 0 -
Protara Therapeutics Inc $ 160 - $ -19 -
Black Diamond Therapeutics Inc $ 855 - $ 0 -
Precipio Inc $ 11 $ 4 $ -11 -
Seneca Biopharma Inc $ 7 $ 0 $ -13 -
Creative Medical Technology Holdings Inc $ 4 - $ 0 -
Ocugen Inc $ 12 - $ -35 -
Biotechnology & Drugs Industry $ 788,108 $ 143,664 $ 10,850 89,094
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry.
Earnings Estimates decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %.


Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year.
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #





Cardiovascular Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FTFC's Profile

Stock Price

FTFC's Financials

Business Description

Fundamentals

Charts & Quotes

FTFC's News

Suppliers

FTFC's Competitors

Customers & Markets

Economic Indicators

FTFC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071